Clinical Trial Update: Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins [NA]

View source ↗

Summary

This clinical trial evaluates stereotactic radiotherapy for prostate cancer with reduced safety margins. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital Ostrava | Conditions: Prostate Cancer (Adenocarcinoma) | NA | Status: RECRUITING